Valuation: Novonesis A/S

Market Cap 205B 30.59B 27.43B 25.28B 22.96B 43.45B 2,868B 44.67B 303B 121B 1,537B 115B 112B 4,857B P/E 2026 *
36x
P/E 2027 * 32x
Enterprise Value 225B 33.58B 30.12B 27.76B 25.21B 47.71B 3,149B 49.04B 332B 132B 1,687B 126B 123B 5,333B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 6.21x
Free-Float
74.08%
Yield 2026 *
1.66%
Yield 2027 * 1.85%
1 day-3.42%
1 week-3.82%
Current month-4.72%
1 month+1.17%
3 months+4.56%
6 months+16.30%
Current year+7.95%
1 week 440.2
Extreme 440.2
484.7
1 month 433.6
Extreme 433.6
484.7
Current year 336.8
Extreme 336.8
484.7
1 year 336.8
Extreme 336.8
484.7
3 years 336.8
Extreme 336.8
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
21/11/25 Buy

Director

2,500 0.0006%
21/11/25 Buy

Director

2,500 0.0006%
7/11/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%-3.82%+6.64%+28.30% 30.59B
-0.23%+0.44%+18.36%+72.02% 85.83B
-0.42%+2.48%+20.08%+27.30% 45.21B
+1.38%+5.98%+27.42%-13.78% 37.66B
+4.37%+7.88%+19.97%+23.56% 36.86B
+1.64%+3.28%+6.23%+24.92% 26.13B
+0.30%-1.65%+53.82%+37.73% 23.66B
+1.12%+2.23%+29.95%-23.93% 20.79B
-4.00%+1.34%+4.92%+16.13% 15.55B
-0.42%+0.60%+31.41%-2.41% 14.33B
Average +0.08%+1.78%+21.88%+18.98% 34B
Weighted average by Cap. +0.24%+1.85%+20.92%+29.39%

Financials

2026 *2027 *
Net sales 33.47B 4.99B 4.48B 4.13B 3.75B 7.09B 468B 7.29B 49.39B 19.68B 251B 18.73B 18.33B 793B 36.02B 5.37B 4.82B 4.44B 4.03B 7.63B 504B 7.84B 53.16B 21.18B 270B 20.16B 19.73B 853B
Net income 5.52B 824M 739M 681M 618M 1.17B 77.21B 1.2B 8.15B 3.25B 41.37B 3.09B 3.03B 131B 6.39B 953M 855M 788M 716M 1.35B 89.4B 1.39B 9.44B 3.76B 47.9B 3.58B 3.5B 151B
Net Debt 20.07B 2.99B 2.68B 2.47B 2.25B 4.25B 281B 4.37B 29.63B 11.8B 150B 11.24B 11B 475B 18.69B 2.79B 2.5B 2.3B 2.09B 3.96B 261B 4.07B 27.59B 10.99B 140B 10.46B 10.24B 443B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
10/11/26 DKK 440.20 -3.42% 1,129,833
09/11/26 DKK 455.80 -0.91% 679,177
06/11/26 DKK 460.00 -4.15% 905,267
05/11/26 DKK 479.90 +4.51% 1,112,390
04/11/26 DKK 459.20 +0.33% 1,217,963
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
440.20DKK
Average target price
509.33DKK
Spread / Average Target
+15.70%
  1. Stock Market
  2. Stocks
  3. NSIS B Stock